🔎 Trials Near Me

Akèy › Hypertension artérielle › Missouri

Etid klinik pou Hypertension artérielle nan Missouri

11 etid pou Hypertension artérielle ap chèche patisipan nan sit nan Missouri.

Vil nan Missouri

Tèks ofisyèl etid la (Anglè)

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

  • CRO Call Center, Overland
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07142356

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Jefferson City Medical Group, Jefferson City
  • Johnson County ClinTrials, Kansas City
  • St. Louis Heart and Vascular, P.C., St Louis
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Clinvest Headlands Llc, Springfield
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07794579

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

  • Research Site, Kansas City
  • Research Site, Kansas City
  • Research Site, St Louis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06742723

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

  • St Lukes Hospital, Kansas City
Ap rekrite
Laj 22 a 75 · Tout sèks · Mizajou Sep 24, 2026 · NCT06559891

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Kansas City
  • Clinical Trial Site, Kansas City
  • Clinical Trial Site, Kansas City
  • ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109

Impact GLP-1 Agonists Following Bariatric

  • University of Missouri Hospital, Columbia
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06132477

Global Paradise System US Post Approval Study

  • Saint Luke's Mid America Heart Institute, Kansas City
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT06297291

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

  • University of Missouri, Columbia
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Aug 7, 2026 · NCT06402968

An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

  • Jefferson City Medical Group, Jefferson City
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07543120

Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension

  • Vanda Investigative Site, Hazelwood
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Feb 27, 2026 · NCT07090161

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.